196 related articles for article (PubMed ID: 23456497)
1. Low expression of cyclinH and cyclin-dependent kinase 7 can decrease the proliferation of human esophageal squamous cell carcinoma.
Zhang J; Yang X; Wang Y; Shi H; Guan C; Yao L; Huang X; Ding Z; Huang Y; Wang H; Cheng C
Dig Dis Sci; 2013 Jul; 58(7):2028-37. PubMed ID: 23456497
[TBL] [Abstract][Full Text] [Related]
2. Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression.
Zhang J; Zhu J; Yang L; Guan C; Ni R; Wang Y; Ji L; Tian Y
Tumour Biol; 2015 Sep; 36(9):6701-14. PubMed ID: 25820824
[TBL] [Abstract][Full Text] [Related]
3. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma.
Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R
Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515
[TBL] [Abstract][Full Text] [Related]
4. High expression of SGTA in esophageal squamous cell carcinoma correlates with proliferation and poor prognosis.
Yang X; Cheng L; Li M; Shi H; Ren H; Ding Z; Liu F; Wang Y; Cheng C
J Cell Biochem; 2014 Jan; 115(1):141-50. PubMed ID: 23939810
[TBL] [Abstract][Full Text] [Related]
5. CDK7 and CCNH are components of CDK-activating kinase and are required for meiotic progression of pig oocytes.
Fujii W; Nishimura T; Kano K; Sugiura K; Naito K
Biol Reprod; 2011 Dec; 85(6):1124-32. PubMed ID: 21778139
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 suppresses tumor growth and metastasis in esophageal squamous cell carcinoma.
Zeng H; Yang H; Song Y; Fang D; Chen L; Zhao Z; Wang C; Xie S
Cell Death Dis; 2021 Nov; 12(11):1048. PubMed ID: 34741018
[TBL] [Abstract][Full Text] [Related]
7. Interaction with cyclin H/cyclin-dependent kinase 7 (CCNH/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration.
Wang Y; Liu F; Mao F; Hang Q; Huang X; He S; Wang Y; Cheng C; Wang H; Xu G; Zhang T; Shen A
J Biol Chem; 2013 Mar; 288(13):9028-34. PubMed ID: 23393140
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of CDK7 is associated with unfavourable prognosis in oral squamous cell carcinoma.
Jiang L; Huang R; Wu Y; Diao P; Zhang W; Li J; Li Z; Wang Y; Cheng J; Yang J
Pathology; 2019 Jan; 51(1):74-80. PubMed ID: 30473182
[TBL] [Abstract][Full Text] [Related]
9. [Expression and clinical significance of cyclin H and CDK7 in human hemangiomas].
Liu J; Zhang DL; Shan SG
Zhonghua Zheng Xing Wai Ke Za Zhi; 2008 Jul; 24(4):300-2. PubMed ID: 18950027
[TBL] [Abstract][Full Text] [Related]
10. 14-3-3σ confers cisplatin resistance in esophageal squamous cell carcinoma cells via regulating DNA repair molecules.
Lai KK; Chan KT; Choi MY; Wang HK; Fung EY; Lam HY; Tan W; Tung LN; Tong DK; Sun RW; Lee NP; Law S
Tumour Biol; 2016 Feb; 37(2):2127-36. PubMed ID: 26346170
[TBL] [Abstract][Full Text] [Related]
11. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A.
Guan C; Shi H; Wang H; Zhang J; Ni W; Chen B; Hou S; Yang X; Shen A; Ni R
J Cell Biochem; 2013 Jun; 114(6):1343-54. PubMed ID: 23255392
[TBL] [Abstract][Full Text] [Related]
12. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
13. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
[TBL] [Abstract][Full Text] [Related]
14. Cyclin H Regulates Lung Cancer Progression as a Carcinoma Inducer.
Mao L; Ling X; Chen J
Comput Math Methods Med; 2021; 2021():6646077. PubMed ID: 33777168
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo].
Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH
Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
[TBL] [Abstract][Full Text] [Related]
17. Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro.
Cheng Y; Li K; Diao D; Zhu K; Shi L; Zhang H; Yuan D; Guo Q; Wu X; Liu D; Dang C
Lab Invest; 2013 Dec; 93(12):1276-87. PubMed ID: 24145239
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclin-dependent kinase 7 silencing on cisplatin sensitivity in endometrial carcinoma cells.
Liu WX; Liu XY; Yu H; Chen Y; Hao Q
Mol Med Rep; 2015 Mar; 11(3):1745-51. PubMed ID: 25411854
[TBL] [Abstract][Full Text] [Related]
19. Silencing HMGN5 suppresses cell growth and promotes chemosensitivity in esophageal squamous cell carcinoma.
Liu X; Ma W; Yan Y; Wu S
J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28914995
[TBL] [Abstract][Full Text] [Related]
20. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway.
Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
